The Greater Manchester Dementia Research Centre (GMDRC) is Greater Manchester's leading clinical trial unit for the diseases causing dementia. We focus on putting the right patient into the right trial at the right time.

We have a 10-year track record of connecting people living with dementia with cutting-edge studies run by industry partners or the National Institute for Health Research (NIHR). We have close links to the University of Manchester through the Faculty of Biology, Medicine and Health and the Geoffrey Jefferson Brain Research Centre (GJBRC).

Locally, with our GM partners, the Manchester Clinical Research Facility and Health Innovation Manchester, we provide the infrastructure and expertise necessary to bring disease-modyfing medications to Greater Manchester.  Together with patients and partners our aim is to be part of a global team that brings the first disease-modifying medications to patients living with dementia. 

We use the state-of-the-art PET-MRI scanner located in St. Mary's Hospital and funded by the Dementias Platform UK to examine the earliest parts of the brain affected by Alzheimer's and other dementias. Nationally, working with the UK Brain Health Network (Bristol, Edinburgh, London, Cambridge, Oxford, Manchester, Newport and Belfast) we aim to bring molecular diagnostics into routine practice in the UK.